Plain-English translation of NCT06676319 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called (SAR443765) given as an injection under the skin every 4 weeks to see if it helps control asthma in adults. The study compares the medication to a placebo injection in people with mild-to-moderate asthma who have had at least one asthma attack in the past year but aren't currently eligible for other biologic treatments. Researchers want to know whether this treatment is safe, well-tolerated, and actually works to prevent asthma attacks.
Many people with asthma have frequent attacks despite taking standard asthma medications, but they may not qualify for existing biologic treatments due to their specific asthma type or other health factors. This trial is looking for a new treatment option for this group of patients.
If you enroll, you'll visit the clinic about 18 times over approximately 60 to 64 weeks, with the active treatment lasting about 52 weeks. You'll receive either the new medication or a placebo injection under your skin every 4 weeks, and the research team will monitor your asthma control, any side effects, and your lung function through blood tests and breathing tests. You'll be asked to track your asthma symptoms and any attacks between visits.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States